Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecnoglutide in Obese Participants With Knee Osteoarthritis
NCT07734311Phase 3Recruiting
- Sponsor
- Sciwind Biosciences
- Start
- Aug 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 3 trial of ecnoglutide in knee osteoarthritis (OA), obesity, sponsored by Sciwind Biosciences. Started Aug 2026; status: recruiting.
02
Drugs
ecnoglutide
03
Conditions
knee osteoarthritis (OA)obesity
Beyond the preview
Go deeper on NCT07734311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07734311.